Elekta (OTCMKTS:EKTAY) Shares Up 0.1% - Here's Why

Key Points

• Elekta AB shares saw a slight increase of 0.1%, closing at $4.80, with a trading volume significantly down to 4,435 shares from the average of 5,601 shares.
• Analysts at Danske have downgraded Elekta's stock to a "hold" rating as of June 3rd.
• The company reported a net margin of 1.15% and earnings of $0.11 per share, which was below the analysts' expectations of $0.13.

Shares of Elekta AB (OTCMKTS:EKTAY - Get Free Report) shot up 0.1% during mid-day trading on Tuesday . The company traded as high as $4.80 and last traded at $4.80. 4,435 shares changed hands during trading, a decline of 21% from the average session volume of 5,601 shares. The stock had previously closed at $4.79.

Wall Street Analyst Weigh In

Separately, Danske cut shares of Elekta to a "hold" rating in a research note on Tuesday, June 3rd.

Elekta Stock Up 0.1%

The firm has a market capitalization of $1.84 billion, a P/E ratio of 95.92 and a beta of 1.19. The firm's fifty day moving average price is $5.04 and its 200-day moving average price is $5.28. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.09 and a quick ratio of 0.86.

Elekta (OTCMKTS:EKTAY - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The company reported $0.11 EPS for the quarter, missing analysts' consensus estimates of $0.13 by ($0.02). The firm had revenue of $503.22 million during the quarter, compared to the consensus estimate of $507.19 million. Elekta had a return on equity of 11.55% and a net margin of 1.15%. As a group, equities research analysts forecast that Elekta AB will post 0.36 earnings per share for the current year.

Elekta Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.